top of page
Latest News
BioCentury Grand Rounds
Ascensus Therapeutics was invited to present at the BioCentury Grand Rounds meeting in Nashville, TN.
​
​​​​​
Sachs Oncology Innovation Forum
Ascensus Therapeutics was invited to present the novel approach and recent progress developed at the 11th Annual Oncology Innovation Forum.
​
Clearance to Initiate First-in-
Human Clinical Trial
Ascensus Therapeutics has received regulatory clearance to begin its first-in-human Phase I/IIa clinical trial of its lead cell therapy for adenocarcinoma. The study will evaluate safety and early biological activity in patients with advanced disease.
​
bottom of page